Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This review brings together the current knowledge regarding the risk factors and the clinical, radiologic, and histological features of both post-COVID-19 pulmonary fibrosis (PCPF) and idiopathic pulmonary fibrosis (IPF), describing the similarities and the disparities between these two diseases, using numerous databases to identify relevant articles published in English through October 2022. This review would help clinicians, pathologists, and researchers make an accurate diagnosis, which can help identify the group of patients selected for anti-fibrotic therapies and future therapeutic perspectives.

Cite

CITATION STYLE

APA

Cîrjaliu, R. E., Deacu, M., Gherghișan, I., Marghescu, A. Ștefania, Enciu, M., Băltățescu, G. I., … Fildan, A. P. (2023, June 1). Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis. Biomedicines. MDPI. https://doi.org/10.3390/biomedicines11061739

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free